Result of AGM & Change of Name of NOMAD & Broker

About this update from Cambridge Cognition Holdings Plc

28 June 2024 Cambridge Cognition Holdings plc ("Cambridge Cognition", the "Company" or the "Group") Result of AGM Change of Name of Nominated Adviser and Joint Broker   Cambridge Cognition plc (AIM: COG) , which develops and markets digital solutions to assess brain health, held its Annual General Meeting ("AGM") earlier today at the registered office of the Company; Tunbridge Court, Tunbridge Lane, Bottisham, Cambridge, CB25 9TU and announces that all resolutions put forward were duly passed.   Proxy votes were received in respect of approximately 55% of the Company's issued share capital and the votes cast were as follows:   Resolution For   Against   Withheld 1 - to approve the 2023 report and accounts 22,321,648 99.98% 5,003 0.02% 642,810 2 - to appoint the auditors 22,930,519 99.96% 8,503 0.04% 30,439 3 - to authorise the directors to set the auditors remuneration 22,942,198 99.98% 5,003 0.02% 22,260 4 - to re-elect Richard Bungay as a director 20,756,611 98.92% 226,842 1.08% 1,986,008 5 - to elect Nick Rodgers as a director 22,927,961 99.82% 40,492 0.18% 1,008 6 - to elect Stuart Gall as a director 22,927,961 99.82% 40,492 0.18% 1,008 7 - authority to allot shares 22,798,499 99.26% 169,954 0.74% 1,008 8 - disapplication of pre-emption rights 22,789,981 99.22% 178,472 0.78% 1,008 9 - disapplication of pre-emption rights in connection with an acquisition or specified capital investment 22,788,299 99.22% 180,154 0.78% 1,008   Change of Name of Nominated Adviser and Broker   The Company also announces that its Nominated Adviser and Joint Broker has changed its name to Panmure Liberum Limited following completion of its own corporate merger.   Enquiries   Cambridge Cognition Holdings plc Matthew Stork, Chief Executive Officer Stephen Symonds, Chief Financial Officer   www.cambridgecognition.com Tel: 01223 810 700   Panmure Liberum Limited (NOMAD & Joint Broker) Freddy Crossley / Emma Earl / Mark Rogers Rupert Dearden Tel: 020 78862500 (Corporate Advisory) (Corporate Broking)   Dowgate Capital Limited (Joint Broker) David Poutney / James Serjeant Tel: 020 3903 7715 (Corporate Broking) Hudson Sandler (Financial PR and IR ) Dan de Belder / Hattie Dreyfus Tel: 020 7796 4133   Notes to Editors   About Cambridge Cognition   Cambridge Cognition is a technology company marketing digital health products to better understand, detect and treat conditions affecting brain health. The Company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.   For further information visit www.cambridgecognition.com  

View stock analysis, news, and events for Cambridge Cognition Holdings Plc